Research into Ovarian Cancer

Reading time: 1 min

Research into ovarian cancer focuses on testing the efficacy of new diagnostic methods, new surgical procedures, and new pharmacological treatments.  

Numerous targeted treatments for ovarian cancer are currently being evaluated through clinical trials. Clinical trials are necessary to objectively evaluate and monitor the activity of these new drugs.   

The great majority of ovarian cancer clinical trials evaluate the role of immunotherapy in combination with other drugs, a treatment that has been effective for other types of cancer and which has shown promising results in ovarian cancer. Immunotherapy is the use of drugs to stimulate the patient's own immune system to recognise and destroy tumour cells more effectively. 

Clinical trials are also underway with new drugs that act on specific therapeutic targets. These have been discovered thanks to our understanding of how tumour cells work.  

In addition, thanks to the development of liquid biopsies, which look at tumour DNA in the circulation and allow the genetic material of the tumour in the patient's blood to be analysed, studies are being carried out to detect changes in tumour biology. This makes it possible to determine when a patient is resistant to a new therapy and it becomes beneficial to change it. 

Clinical research

Discover the projects and active clinical trials on this disease.
Go to list

Substantiated information by:

Lydia Gaba

Published: 3 July 2020
Updated: 3 July 2020

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.


Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.